Gsk (GSK) Equity Income (2009 - 2026)
Gsk (GSK) recorded Equity Income of -$9.4 million in the quarter ended Sep 8, 2026.
Analysis
Gsk (GSK) Equity Income (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's Equity Income came in at -$20.15 million as of Sep 8, 2026; for the year ended Dec 31, 2025, it came in at -$2.64 million.
- Across earlier years, Equity Income came in at $7.67 million in the year ended Dec 31, 2024, -$6.22 million in the year ended Dec 31, 2023, -$3.71 million in the year ended Dec 31, 2022 and $45.4 million in the year ended Dec 31, 2021 (+7.1%).
- The figure for the quarter ended Sep 8, 2026 is the lowest quarterly Equity Income in data going back to the quarter ended Dec 31, 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | - |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | - |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | - |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | - |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | -4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.03 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | 5.40 Mn |
| Jun 30, 2025 | -2.67 Mn |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | -6.21 Mn |
| Sep 30, 2023 | 5.07 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | -2.35 Mn |
| Sep 30, 2022 | -1.18 Mn |
| Jun 30, 2022 | -2.52 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | -2.70 Mn |
| Sep 30, 2021 | 4.14 Mn |
| Jun 30, 2021 | 22.36 Mn |
API Access
Gsk Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();